Search Result "Raf-MEK-ERK signaling pathway"
Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 1 Year: 2009 Page: 28-35
Author(s): Kwong-Kwok Wong
The Therapeutic Promise of Anti-Cancer Drugs Against the Ras/Raf/MEK/ERK Pathway
Ebook: Topics in Anti-Cancer Research
Volume: 2 Year: 2013
Author(s): Erin K. Crane,Kwong-Kwok Wong
Doi: 10.2174/9781608051366113020006
Signaling Through RAS-RAF-MEK-ERK: from Basics to Bedside
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 5 Year: 2007 Page: 601-623
Author(s): Armin Zebisch, Armin P. Czernilofsky, Gyorgy Keri, Julja Smigelskaite, Heinz Sill, Jakob Troppmair
Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments
Journal: Current Signal Transduction Therapy
Volume: 4 Issue: 2 Year: 2009 Page: 130-143
Author(s): Ludovica Ciuffreda, James A. McCubrey, Michele Milella
FOXD3 Suppresses the Proliferation of CRC Bone Metastatic Cells via theRas/Raf/MEK/ERK Signaling Pathway
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 27 Issue: 3 Year: 2024 Page: 436-445
Author(s):
Signal Transduction Pathways in Cancer
Ebook: Molecular Oncology: Principles and Recent Advances
Volume: 1 Year: 2012
Author(s): Lucrecia Marquez-Rosado
Doi: 10.2174/978160805016111201010098
Targeting Signalling Pathways in Hepatocellular Carcinoma
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 1 Year: 2017 Page: 170-175
Author(s): Kaja Blagotinsek,Damjana Rozman
Recent Advances of MEK Inhibitors and Their Clinical Progress
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1364-1378
Author(s): Wang John (Yuan), Wilcoxen M. Keith, Nomoto Kenichi, Wu Sara
The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunates Activity in Cancer Cells
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 72-80
Author(s): V. Badireenath Konkimalla, James A. McCubrey, Thomas Efferth
Extracellular Signal-Regulated Kinases Modulate DNA Damage Response - A Contributing Factor to Using MEK Inhibitors in Cancer Therapy
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 5476-5482
Author(s): F. Wei, J. Yan, D. Tang